24/7 Market News- Kraig Biocraft Laboratories Receives Spider Silk Order from Global Performance Sports Brand, Marking Several Major Milestones

Move a Key Commercialization Catalyst

DENVER, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories (OTCQB: KBLB) (“Kraig Labs” or “the Company”) announced a major milestone in the commercialization of its recombinant spider silk platform, confirming that it is now fulfilling an order for customized spider silk yarns from a globally recognized performance sports apparel brand, as part of a confidential pilot development program to create a special product, which is under strict confidentiality until the sports apparel brand releases it.

This order, though small by design, marks one of the most significant commercialization steps in the Company’s history and a major milestone long anticipated by many shareholders, as Kraig Labs begins delivering spider silk super fibers engineered for elite-tier athletic applications. The collaboration validates the company’s position as the first and only commercial entity to demonstrate scalable high-performance recombinant spider silk production using traditional sericulture methods.

Delivering Spider Silk Super Fibers; A Real-World Breakthrough

Kraig Labs is currently processing a portion of its next-generation spider silk inventory into purpose-built, customer-specified yarns, which are expected to ship before the end of the first quarter. These materials will be used by the customer’s engineering team in a cutting-edge, high-performance application known for its demanding technical requirements.

While details of the initiative remain protected under confidentiality restrictions, the Company confirmed that the application is positioned at the highest tier of the global performance apparel market, where durability, tensile strength, elasticity, and weight-to-performance ratios are critical. Spider silk has long been viewed as the “holy grail” of textile materials due to its unique combination of properties, qualities that have inspired billions of dollars in global R&D attempts by synthetic biology giants, Fortune 500 apparel brands, leading chemical companies, and government-funded laboratories. Despite this, Kraig Labs stands alone in having achieved multiple “firsts” in the commercialization, scalability, and real-world deployment of recombinant spider silk.